Richard Christopher - Net Worth and Insider Trading
Richard Christopher Net Worth
The estimated net worth of Richard Christopher is at least $7 Million dollars as of 2024-12-28. Richard Christopher is the VP Finance & CFO of Davis Select U.S. Equity ETF and owns about 151,002 shares of Davis Select U.S. Equity ETF (DUSA) stock worth over $6 Million. Richard Christopher is also the CEO of Lexaria Bioscience Corp and owns about 50,000 shares of Lexaria Bioscience Corp (LEXX) stock worth over $114,500. Details can be seen in Richard Christopher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Christopher has not made any transactions after 2024-12-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Christopher
Richard Christopher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Christopher owns 3 companies in total, including InVivo Therapeutics Holdings Corp (NVIVQ) , icad Inc (ICAD) , and Caliber Imaging & Diagnostics Inc (LCDX) .
Click here to see the complete history of Richard Christopher’s form 4 insider trades.
Insider Ownership Summary of Richard Christopher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVIVQ | InVivo Therapeutics Holdings Corp | 2022-11-17 | Chief Financial Officer |
| ICAD | icad Inc | 2016-11-04 | Chief Financial Officer & EVPF |
| LCDX | Caliber Imaging & Diagnostics Inc | 2014-03-18 | Chief Financial Officer |
Richard Christopher Latest Holdings Summary
Richard Christopher currently owns a total of 2 stocks. Among these stocks, Richard Christopher owns 151,002 shares of Davis Select U.S. Equity ETF (DUSA) as of May 12, 2011, with a value of $6 Million and a weighting of 98.25%. Richard Christopher also owns 50,000 shares of Lexaria Bioscience Corp (LEXX) as of December 3, 2024, with a value of $114,500 and a weighting of 1.75%.
Latest Holdings of Richard Christopher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DUSA | Davis Select U.S. Equity ETF | 2011-05-12 | 151,002 | 42.47 | 6,413,055 |
| LEXX | Lexaria Bioscience Corp | 2024-12-03 | 50,000 | 2.29 | 114,500 |
Holding Weightings of Richard Christopher
Richard Christopher Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Christopher has made a total of 0 transactions in Davis Select U.S. Equity ETF (DUSA) over the past 5 years. The most-recent trade in Davis Select U.S. Equity ETF is the sale of 42,550 shares on May 12, 2011, which brought Richard Christopher around $252,747.
According to the SEC Form 4 filings, Richard Christopher has made a total of 1 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 50,000 shares on December 3, 2024, which cost Richard Christopher around $118,500.
Insider Trading History of Richard Christopher
- 1
Richard Christopher Trading Performance
Richard Christopher Ownership Network
Richard Christopher Owned Company Details
What does InVivo Therapeutics Holdings Corp do?
Who are the key executives at InVivo Therapeutics Holdings Corp?
Richard Christopher is the Chief Financial Officer of InVivo Therapeutics Holdings Corp. Other key executives at InVivo Therapeutics Holdings Corp include 10 percent owner Brice Foose , director & CEO and CMO Richard M. Toselli , and Chief Legal Officer and GC Heather Hamel .
InVivo Therapeutics Holdings Corp (NVIVQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
InVivo Therapeutics Holdings Corp (NVIVQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
InVivo Therapeutics Holdings Corp Insider Transactions
Richard Christopher Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Christopher. You might contact Richard Christopher via mailing address: C/o Lucid, Inc., 50 Methodist Hill Dr, Suite 1000, Rochester Ny 14623.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
